Trademark: 97110446
Word
FEXTENFA
Status
Pending
Status Code
732
Status Date
Tuesday, February 20, 2024
Serial Number
97110446
Mark Type
4000
Filing Date
Friday, November 5, 2021
Published for Opposition
Tuesday, June 28, 2022

Trademark Owner History
TEVA PHARMACEUTICALS USA, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment of alimentary, anti-parasitic, autoimmune, blood-related, cancer, cardiovascular, central nervous system, dermatological, endocrine, gastrointestinal, immunological, infectious, inflammatory, menopausal, musculo-skeletal, neurological, opthalmological, pain, renal, metabolic, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for use in hematology

Trademark Events
Feb 21, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 20, 2024
Sou Extension 3 Granted
Feb 20, 2024
Sou Extension 3 Filed
Feb 20, 2024
Sou Teas Extension Received
Aug 18, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 16, 2023
Sou Extension 2 Granted
Aug 16, 2023
Sou Extension 2 Filed
Aug 16, 2023
Sou Teas Extension Received
Feb 16, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 14, 2023
Sou Extension 1 Granted
Feb 14, 2023
Sou Extension 1 Filed
Feb 14, 2023
Sou Teas Extension Received
Aug 23, 2022
Noa E-Mailed - Sou Required From Applicant
Jun 28, 2022
Official Gazette Publication Confirmation E-Mailed
Jun 28, 2022
Published For Opposition
Jun 8, 2022
Notification Of Notice Of Publication E-Mailed
May 25, 2022
Approved For Pub - Principal Register
May 25, 2022
Assigned To Examiner
Nov 15, 2021
New Application Office Supplied Data Entered
Nov 9, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24